APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydromorphone

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Hydromorphone Industry Growth and Trends Forecast to 2032

19 December 2025117 pages

Choose your research edition.

Industry ResearchHydromorphone Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydromorphone Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Hydromorphone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydromorphone Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydromorphone Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Hydromorphone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hydromorphone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hydromorphone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hydromorphone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hydromorphone include Teva Pharmaceuticals, Johnson & Johnson, Novartis, Mylan, Pfizer, Fresenius, Watson Laboratories, Stada Arzneimittel and Purdue Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hydromorphone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hydromorphone market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hydromorphone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hydromorphone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hydromorphone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hydromorphone Market by Company

Teva Pharmaceuticals

Johnson & Johnson

Novartis

Mylan

Pfizer

Fresenius

Watson Laboratories

Stada Arzneimittel

Purdue Pharma

Mundipharma

Mallinckrodt

Lannett

KV Pharmaceutical

Barr Pharmaceuticals

Apotex

Akorn

Hydromorphone Segment by Type

Oral

Injection

Hydromorphone Segment by Application

Hospital

Drug Store

Hydromorphone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydromorphone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydromorphone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydromorphone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hydromorphone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hydromorphone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Injection Table 3. Global Hydromorphone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Hydromorphone Sales by Type (2021-2026) & (K Units) Table 5. Global Hydromorphone Sales Market Share in Volume by Type (2021-2026) Table 6. Global Hydromorphone Sales by Type (2021-2026) & (US$ Million) Table 7. Global Hydromorphone Sales Market Share in Value by Type (2021-2026) Table 8. Global Hydromorphone Price by Type (2021-2026) & (US$/Unit) Table 9. Global Hydromorphone Sales by Type (2027-2032) & (K Units) Table 10. Global Hydromorphone Sales Market Share in Volume by Type (2027-2032) Table 11. Global Hydromorphone Sales by Type (2027-2032) & (US$ Million) Table 12. Global Hydromorphone Sales Market Share in Value by Type (2027-2032) Table 13. Global Hydromorphone Price by Type (2027-2032) & (US$/Unit) Table 14. North America Hydromorphone Sales by Type (2021-2026) & (K Units) Table 15. North America Hydromorphone Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Hydromorphone Sales by Type (2021-2026) & (K Units) Table 17. Europe Hydromorphone Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Hydromorphone Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Hydromorphone Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Hydromorphone Sales by Type (2021-2026) & (K Units) Table 21. Latin America Hydromorphone Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Hydromorphone Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Hydromorphone Sales by Type (2021-2026) & (US$ Million) Table 24. Hydromorphone Industry Trends Table 25. Hydromorphone Industry Drivers Table 26. Hydromorphone Industry Opportunities and Challenges Table 27. Hydromorphone Industry Restraints Table 28. Global Hydromorphone Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Hydromorphone Revenue Market Share by Company (2021-2026) Table 30. Global Hydromorphone Sales by Company (2021-2026) & (K Units) Table 31. Global Hydromorphone Sales Share by Company (2021-2026) Table 32. Global Hydromorphone Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Hydromorphone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Hydromorphone Major Company Production Sites and Headquarters Table 35. Global Hydromorphone Company, Product Type & Application Table 36. Global Hydromorphone Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Hydromorphone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Hydromorphone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Hydromorphone Sales by Region (2021-2026) & (K Units) Table 41. Global Hydromorphone Sales Market Share in Volume by Region (2021-2026) Table 42. Global Hydromorphone Sales by Region (2021-2026) & (US$ Million) Table 43. Global Hydromorphone Sales Market Share in Value by Region (2021-2026) Table 44. Global Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Hydromorphone Sales by Region (2027-2032) & (K Units) Table 46. Global Hydromorphone Sales Market Share in Volume by Region (2027-2032) Table 47. Global Hydromorphone Sales by Region (2027-2032) & (US$ Million) Table 48. Global Hydromorphone Sales Market Share in Value by Region (2027-2032) Table 49. Global Hydromorphone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Hydromorphone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Hydromorphone Sales by Application (2021-2026) & (K Units) Table 52. Global Hydromorphone Sales Market Share in Volume by Application (2021-2026) Table 53. Global Hydromorphone Sales by Application (2021-2026) & (US$ Million) Table 54. Global Hydromorphone Sales Market Share in Value by Application (2021-2026) Table 55. Global Hydromorphone Price by Application (2021-2026) & (US$/Unit) Table 56. Global Hydromorphone Sales by Application (2027-2032) & (K Units) Table 57. Global Hydromorphone Sales Market Share in Volume by Application (2027-2032) Table 58. Global Hydromorphone Sales by Application (2027-2032) & (US$ Million) Table 59. Global Hydromorphone Sales Market Share in Value by Application (2027-2032) Table 60. Global Hydromorphone Price by Application (2027-2032) & (US$/Unit) Table 61. North America Hydromorphone Sales by Application (2021-2026) & (K Units) Table 62. North America Hydromorphone Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Hydromorphone Sales by Application (2021-2026) & (K Units) Table 64. Europe Hydromorphone Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Hydromorphone Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Hydromorphone Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Hydromorphone Sales by Application (2021-2026) & (K Units) Table 68. Latin America Hydromorphone Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Hydromorphone Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Hydromorphone Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Pharmaceuticals Company Information Table 72. Teva Pharmaceuticals Business Overview Table 73. Teva Pharmaceuticals Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Teva Pharmaceuticals Hydromorphone Product Portfolio Table 75. Teva Pharmaceuticals Recent Development Table 76. Johnson & Johnson Company Information Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Johnson & Johnson Hydromorphone Product Portfolio Table 80. Johnson & Johnson Recent Development Table 81. Novartis Company Information Table 82. Novartis Business Overview Table 83. Novartis Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Novartis Hydromorphone Product Portfolio Table 85. Novartis Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Mylan Hydromorphone Product Portfolio Table 90. Mylan Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Pfizer Hydromorphone Product Portfolio Table 95. Pfizer Recent Development Table 96. Fresenius Company Information Table 97. Fresenius Business Overview Table 98. Fresenius Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Fresenius Hydromorphone Product Portfolio Table 100. Fresenius Recent Development Table 101. Watson Laboratories Company Information Table 102. Watson Laboratories Business Overview Table 103. Watson Laboratories Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Watson Laboratories Hydromorphone Product Portfolio Table 105. Watson Laboratories Recent Development Table 106. Stada Arzneimittel Company Information Table 107. Stada Arzneimittel Business Overview Table 108. Stada Arzneimittel Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Stada Arzneimittel Hydromorphone Product Portfolio Table 110. Stada Arzneimittel Recent Development Table 111. Purdue Pharma Company Information Table 112. Purdue Pharma Business Overview Table 113. Purdue Pharma Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Purdue Pharma Hydromorphone Product Portfolio Table 115. Purdue Pharma Recent Development Table 116. Mundipharma Company Information Table 117. Mundipharma Business Overview Table 118. Mundipharma Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Mundipharma Hydromorphone Product Portfolio Table 120. Mundipharma Recent Development Table 121. Mallinckrodt Company Information Table 122. Mallinckrodt Business Overview Table 123. Mallinckrodt Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Mallinckrodt Hydromorphone Product Portfolio Table 125. Mallinckrodt Recent Development Table 126. Lannett Company Information Table 127. Lannett Business Overview Table 128. Lannett Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Lannett Hydromorphone Product Portfolio Table 130. Lannett Recent Development Table 131. KV Pharmaceutical Company Information Table 132. KV Pharmaceutical Business Overview Table 133. KV Pharmaceutical Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. KV Pharmaceutical Hydromorphone Product Portfolio Table 135. KV Pharmaceutical Recent Development Table 136. Barr Pharmaceuticals Company Information Table 137. Barr Pharmaceuticals Business Overview Table 138. Barr Pharmaceuticals Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Barr Pharmaceuticals Hydromorphone Product Portfolio Table 140. Barr Pharmaceuticals Recent Development Table 141. Apotex Company Information Table 142. Apotex Business Overview Table 143. Apotex Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Apotex Hydromorphone Product Portfolio Table 145. Apotex Recent Development Table 146. Akorn Company Information Table 147. Akorn Business Overview Table 148. Akorn Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Akorn Hydromorphone Product Portfolio Table 150. Akorn Recent Development Table 151. North America Hydromorphone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. North America Hydromorphone Sales by Country (2021-2026) & (K Units) Table 153. North America Hydromorphone Sales Market Share by Country (2021-2026) Table 154. North America Hydromorphone Sales Forecast by Country (2027-2032) & (K Units) Table 155. North America Hydromorphone Sales Market Share Forecast by Country (2027-2032) Table 156. North America Hydromorphone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. North America Hydromorphone Market Size by Country (2021-2026) & (US$ Million) Table 158. North America Hydromorphone Market Share by Country (2021-2026) Table 159. North America Hydromorphone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. North America Hydromorphone Market Share Forecast by Country (2027-2032) Table 161. Europe Hydromorphone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Europe Hydromorphone Sales by Country (2021-2026) & (K Units) Table 163. Europe Hydromorphone Sales Market Share by Country (2021-2026) Table 164. Europe Hydromorphone Sales Forecast by Country (2027-2032) & (K Units) Table 165. Europe Hydromorphone Sales Market Share Forecast by Country (2027-2032) Table 166. Europe Hydromorphone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Europe Hydromorphone Market Size by Country (2021-2026) & (US$ Million) Table 168. Europe Hydromorphone Market Share by Country (2021-2026) Table 169. Europe Hydromorphone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Europe Hydromorphone Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Hydromorphone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Hydromorphone Sales by Country (2021-2026) & (K Units) Table 173. Asia-Pacific Hydromorphone Sales Market Share by Country (2021-2026) Table 174. Asia-Pacific Hydromorphone Sales Forecast by Country (2027-2032) & (K Units) Table 175. Asia-Pacific Hydromorphone Sales Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Hydromorphone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Hydromorphone Market Size by Country (2021-2026) & (US$ Million) Table 178. Asia-Pacific Hydromorphone Market Share by Country (2021-2026) Table 179. Asia-Pacific Hydromorphone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Asia-Pacific Hydromorphone Market Share Forecast by Country (2027-2032) Table 181. Latin America Hydromorphone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Latin America Hydromorphone Sales by Country (2021-2026) & (K Units) Table 183. Latin America Hydromorphone Sales Market Share by Country (2021-2026) Table 184. Latin America Hydromorphone Sales Forecast by Country (2027-2032) & (K Units) Table 185. Latin America Hydromorphone Sales Market Share Forecast by Country (2027-2032) Table 186. Latin America Hydromorphone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Latin America Hydromorphone Market Size by Country (2021-2026) & (US$ Million) Table 188. Latin America Hydromorphone Market Share by Country (2021-2026) Table 189. Latin America Hydromorphone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Latin America Hydromorphone Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Hydromorphone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Hydromorphone Sales by Country (2021-2026) & (K Units) Table 193. Middle East and Africa Hydromorphone Sales Market Share by Country (2021-2026) Table 194. Middle East and Africa Hydromorphone Sales Forecast by Country (2027-2032) & (K Units) Table 195. Middle East and Africa Hydromorphone Sales Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Hydromorphone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Hydromorphone Market Size by Country (2021-2026) & (US$ Million) Table 198. Middle East and Africa Hydromorphone Market Share by Country (2021-2026) Table 199. Middle East and Africa Hydromorphone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Middle East and Africa Hydromorphone Market Share Forecast by Country (2027-2032) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Hydromorphone Distributors List Table 204. Hydromorphone Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Hydromorphone Image Figure 2. Global Hydromorphone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydromorphone Market Size (2021-2032) & (US$ Million) Figure 4. Global Hydromorphone Sales (2021-2032) & (K Units) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Hydromorphone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Hydromorphone Market Share by Type 2025 VS 2032 Figure 11. North America Hydromorphone Sales Market Share in Volume by Type in 2025 Figure 12. North America Hydromorphone Sales Market Share in Value by Type in 2025 Figure 13. Europe Hydromorphone Sales Market Share in Volume by Type in 2025 Figure 14. Europe Hydromorphone Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Hydromorphone Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Hydromorphone Sales Market Share in Value by Type in 2025 Figure 17. Latin America Hydromorphone Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Hydromorphone Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Hydromorphone Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Hydromorphone Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Hydromorphone Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Drug Store Image Figure 26. Global Drug Store Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Hydromorphone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Hydromorphone Market Share by Application 2025 VS 2032 Figure 29. North America Hydromorphone Sales Market Share in Volume by Application in 2025 Figure 30. North America Hydromorphone Sales Market Share in Value by Application in 2025 Figure 31. Europe Hydromorphone Sales Market Share in Volume by Application in 2025 Figure 32. Europe Hydromorphone Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Hydromorphone Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Hydromorphone Sales Market Share in Value by Application in 2025 Figure 35. Latin America Hydromorphone Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Hydromorphone Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Hydromorphone Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Hydromorphone Sales Market Share in Value by Application in 2025 Figure 39. North America Hydromorphone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Hydromorphone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Hydromorphone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Hydromorphone Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Hydromorphone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Hydromorphone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Hydromorphone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Hydromorphone Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Hydromorphone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Hydromorphone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Hydromorphone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Hydromorphone Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Hydromorphone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Hydromorphone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Hydromorphone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Hydromorphone Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Hydromorphone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Hydromorphone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Hydromorphone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Hydromorphone Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Hydromorphone Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Hydromorphone Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Hospital
  • Drug Store
Companies covered
  • Teva Pharmaceuticals
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Pfizer
  • Fresenius
  • Watson Laboratories
  • Stada Arzneimittel
  • Purdue Pharma
  • Mundipharma
  • Mallinckrodt
  • Lannett
  • KV Pharmaceutical
  • Barr Pharmaceuticals
  • Apotex
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hydromorphone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hydromorphone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hydromorphone Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Injection
  8. 1.4 Global Hydromorphone Market Size by Type
  9. 1.4.1 Global Hydromorphone Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Hydromorphone Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Hydromorphone Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Hydromorphone Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Hydromorphone Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Hydromorphone Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Hydromorphone Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Hydromorphone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hydromorphone Industry Trends
  2. 2.2 Hydromorphone Industry Drivers
  3. 2.3 Hydromorphone Industry Opportunities and Challenges
  4. 2.4 Hydromorphone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hydromorphone Revenue (2021-2026)
  2. 3.2 Global Top Players by Hydromorphone Sales (2021-2026)
  3. 3.3 Global Top Players by Hydromorphone Price (2021-2026)
  4. 3.4 Global Hydromorphone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hydromorphone Major Company Production Sites & Headquarters
  6. 3.6 Global Hydromorphone Company, Product Type & Application
  7. 3.7 Global Hydromorphone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hydromorphone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hydromorphone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hydromorphone Tier 1, Tier 2, and Tier 3
4 Hydromorphone Regional Status and Outlook
  1. 4.1 Global Hydromorphone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hydromorphone Historic Market Size by Region
  3. 4.2.1 Global Hydromorphone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hydromorphone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hydromorphone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hydromorphone Forecasted Market Size by Region
  7. 4.3.1 Global Hydromorphone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hydromorphone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hydromorphone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hydromorphone by Application
  1. 5.1 Hydromorphone Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Hydromorphone Market Size by Application
  5. 5.2.1 Global Hydromorphone Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Hydromorphone Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Hydromorphone Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Hydromorphone Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Hydromorphone Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Hydromorphone Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Hydromorphone Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Hydromorphone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceuticals
  2. 6.1.1 Teva Pharmaceuticals Company Information
  3. 6.1.2 Teva Pharmaceuticals Business Overview
  4. 6.1.3 Teva Pharmaceuticals Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceuticals Hydromorphone Product Portfolio
  6. 6.1.5 Teva Pharmaceuticals Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Hydromorphone Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Hydromorphone Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Hydromorphone Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Hydromorphone Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Fresenius
  32. 6.6.1 Fresenius Company Information
  33. 6.6.2 Fresenius Business Overview
  34. 6.6.3 Fresenius Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Fresenius Hydromorphone Product Portfolio
  36. 6.6.5 Fresenius Recent Developments
  37. 6.7 Watson Laboratories
  38. 6.7.1 Watson Laboratories Company Information
  39. 6.7.2 Watson Laboratories Business Overview
  40. 6.7.3 Watson Laboratories Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Watson Laboratories Hydromorphone Product Portfolio
  42. 6.7.5 Watson Laboratories Recent Developments
  43. 6.8 Stada Arzneimittel
  44. 6.8.1 Stada Arzneimittel Company Information
  45. 6.8.2 Stada Arzneimittel Business Overview
  46. 6.8.3 Stada Arzneimittel Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Stada Arzneimittel Hydromorphone Product Portfolio
  48. 6.8.5 Stada Arzneimittel Recent Developments
  49. 6.9 Purdue Pharma
  50. 6.9.1 Purdue Pharma Company Information
  51. 6.9.2 Purdue Pharma Business Overview
  52. 6.9.3 Purdue Pharma Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Purdue Pharma Hydromorphone Product Portfolio
  54. 6.9.5 Purdue Pharma Recent Developments
  55. 6.10 Mundipharma
  56. 6.10.1 Mundipharma Company Information
  57. 6.10.2 Mundipharma Business Overview
  58. 6.10.3 Mundipharma Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mundipharma Hydromorphone Product Portfolio
  60. 6.10.5 Mundipharma Recent Developments
  61. 6.11 Mallinckrodt
  62. 6.11.1 Mallinckrodt Company Information
  63. 6.11.2 Mallinckrodt Business Overview
  64. 6.11.3 Mallinckrodt Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Mallinckrodt Hydromorphone Product Portfolio
  66. 6.11.5 Mallinckrodt Recent Developments
  67. 6.12 Lannett
  68. 6.12.1 Lannett Company Information
  69. 6.12.2 Lannett Business Overview
  70. 6.12.3 Lannett Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Lannett Hydromorphone Product Portfolio
  72. 6.12.5 Lannett Recent Developments
  73. 6.13 KV Pharmaceutical
  74. 6.13.1 KV Pharmaceutical Company Information
  75. 6.13.2 KV Pharmaceutical Business Overview
  76. 6.13.3 KV Pharmaceutical Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 KV Pharmaceutical Hydromorphone Product Portfolio
  78. 6.13.5 KV Pharmaceutical Recent Developments
  79. 6.14 Barr Pharmaceuticals
  80. 6.14.1 Barr Pharmaceuticals Company Information
  81. 6.14.2 Barr Pharmaceuticals Business Overview
  82. 6.14.3 Barr Pharmaceuticals Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Barr Pharmaceuticals Hydromorphone Product Portfolio
  84. 6.14.5 Barr Pharmaceuticals Recent Developments
  85. 6.15 Apotex
  86. 6.15.1 Apotex Company Information
  87. 6.15.2 Apotex Business Overview
  88. 6.15.3 Apotex Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Apotex Hydromorphone Product Portfolio
  90. 6.15.5 Apotex Recent Developments
  91. 6.16 Akorn
  92. 6.16.1 Akorn Company Information
  93. 6.16.2 Akorn Business Overview
  94. 6.16.3 Akorn Hydromorphone Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Akorn Hydromorphone Product Portfolio
  96. 6.16.5 Akorn Recent Developments
7 North America by Country
  1. 7.1 North America Hydromorphone Sales by Country
  2. 7.1.1 North America Hydromorphone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hydromorphone Sales by Country (2021-2026)
  4. 7.1.3 North America Hydromorphone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hydromorphone Market Size by Country
  6. 7.2.1 North America Hydromorphone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hydromorphone Market Size by Country (2021-2026)
  8. 7.2.3 North America Hydromorphone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hydromorphone Sales by Country
  2. 8.1.1 Europe Hydromorphone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hydromorphone Sales by Country (2021-2026)
  4. 8.1.3 Europe Hydromorphone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hydromorphone Market Size by Country
  6. 8.2.1 Europe Hydromorphone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hydromorphone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hydromorphone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hydromorphone Sales by Country
  2. 9.1.1 Asia-Pacific Hydromorphone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hydromorphone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hydromorphone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hydromorphone Market Size by Country
  6. 9.2.1 Asia-Pacific Hydromorphone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hydromorphone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hydromorphone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hydromorphone Sales by Country
  2. 10.1.1 South America Hydromorphone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hydromorphone Sales by Country (2021-2026)
  4. 10.1.3 South America Hydromorphone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hydromorphone Market Size by Country
  6. 10.2.1 South America Hydromorphone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hydromorphone Market Size by Country (2021-2026)
  8. 10.2.3 South America Hydromorphone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hydromorphone Sales by Country
  2. 11.1.1 Middle East and Africa Hydromorphone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hydromorphone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hydromorphone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hydromorphone Market Size by Country
  6. 11.2.1 Middle East and Africa Hydromorphone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hydromorphone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hydromorphone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hydromorphone Value Chain Analysis
  2. 12.1.1 Hydromorphone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hydromorphone Production Mode & Process
  7. 12.2 Hydromorphone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hydromorphone Distributors
  10. 12.2.3 Hydromorphone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst